Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Quorum Health said the move will allow it to save money through tax exemptions and provide its 11 hospitals with access to the 340B Drug Pricing Program. The health system is majority-owned by Goldentree Asset Management.
The acquisition of SPR Therapeutics will allow Medtronic to expand its portfolio of neuromodulator medical devices. The deal is expected to close in 2027.
These third-party marketers earn commissions from their insurer clients not only upon initial signups but also every time “their” enrollees renew without changing plans.
The agency cited free speech as its reasoning for rescinding the long-standing policy. While in place, the rule barred companies that agreed to settlements with the Securities and Exchange Commission from publicly denying allegations made by regulators.
RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model.
COVID-19 set back screening mammography further than any other category of breast care, dropping schedule adherence during infection peaks to 36% of pre-pandemic rates.
MRI techs earned an average of $76,177 in 2019 and are making $82,395 in 2022. In fact, radiologic technologists across all modalities enjoyed a collective raise of 11.2% during that window.
Harvard researchers have piloted a curriculum for instructing radiology trainees in the business of modern medicine. The teaching team says its program is adaptable by any academic radiology operation.
Florida-based Strategic Radiology announced the addition June 1, naming 11-radiologist Radiology Consultants of Lynchburg in Virginia as its 32nd member practice overall and its second in the Old Dominion state.
Researchers have combined three emerging technologies to detect and classify breast cancers found in follow-up imaging of women whose recent screening mammography was deemed normal.